✦ LIBER ✦

Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy

✍ Scribed by J-Y Blay; M van Glabbeke; J Verweij; A.T van Oosterom; A Le Cesne; J.W Oosterhuis; I Judson; O.S Nielsen

Book ID: 117659140
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 135 KB
Volume: 39
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00480-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of non-frail elderly patients t

Survival of non-frail elderly patients treated with chemotherapy for soft tissue sarcoma: A comparison with non-elderly patients

✍ Nara, E.; Kodaira, M.; Yamamoto, H.; Yunokawa, M.; Yonemori, K.; Shimizu, C.; Fu 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 45 KB

Gemcitabine and vinorelbine combination

Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas : Results of a phase II trial

✍ Palma Dileo; Jeffrey A. Morgan; David Zahrieh; Jayesh Desai; Jeanine M. Salesi; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract ## BACKGROUND. Single‐agent gemcitabine and vinorelbine have activity in treatment of patients with soft‐tissue sarcomas. The combination of gemcitabine plus vinorelbine has activity against several forms of metastatic carcinoma with acceptable toxicity. This study evaluated the effica

27 P - Second line chemotherapy with mod

27 P - Second line chemotherapy with modulation of drug resistance in patients with advanced soft tissue sarcoma

✍ I. Michl; M. Krainer; A. Budinsky; T. Brodowicz; Ch Wiltschke; C.C. Zielinski 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 177 KB

9430 Efficacy and toxicity of sorafenib

9430 Efficacy and toxicity of sorafenib in patients with advanced soft tissue sarcoma failing anthracycline-based chemotherapy

✍ Bertuzzi, A.; Stroppa, E.; Secondino, S.; Zucali, P.; Quagliuolo, V.; Pedrazzoli 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Revision of inadequately treated soft-ti

Revision of inadequately treated soft-tissue sarcoma is associated with increased need for plastic or reconstructive surgery

✍ M. Zacherl; C. Giessauf; M. Glehr; G. Gruber; W. Maurer-Ertl; G. Schwantzer; B. 📂 Article 📅 2009 🏛 Blackwell Publishing 🌐 German ⚖ 453 KB

18FDG-Positron emission tomography for t

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)

✍ S. Stroobants; J. Goeminne; M. Seegers; S. Dimitrijevic; P. Dupont; J. Nuyts; M. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 286 KB